Search research articles
Contact Us
Filters
Showing results (111-120 of 517) with videos related to
Page
of 52
Sort By:
Drug News & Perspectives
|
December 13, 2006
Therapeutic treatments for Alzheimer's disease based on metal bioavailability
Peter J Crouch, Kevin J Barnham, Ashley I Bush, et al.
Molecular Psychiatry
|
October 26, 2016
Glutathione peroxidase 4: a new player in neurodegeneration?
B R Cardoso, D J Hare, A I Bush, et al.
The New England Journal of Medicine
|
August 28, 1980
The accuracy of the rectal examination in the diagnosis of prostate carcinoma
P Guinan, I Bush, V Ray, et al.
Parkinsonism & Related Disorders
|
November 1, 2018
Parkinson's disease prevalence and the association with rurality and agricultural determinants
Darshini Ayton, Scott Ayton, Anna L Barker, et al.
Metallomics : Integrated Biometal Science
|
May 22, 2015
Selenium, selenoproteins and neurodegenerative diseases
Bárbara Rita Cardoso, Blaine R Roberts, Ashley I Bush, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
June 6, 2009
beta-Amyloid as a molecular therapeutic target in Alzheimer's disease
Paul A Adlard, Simon A James, Ashley I Bush, et al.
International Journal of Alzheimer'S Disease
|
December 7, 2011
Disturbed copper bioavailability in Alzheimer's disease
Daniela Kaden, Ashley I Bush, Ruth Danzeisen, et al.
Biochimica Et Biophysica Acta. General Subjects
|
August 8, 2021
Copper and lipid metabolism: A reciprocal relationship
Bryce Blades, Scott Ayton, Ya Hui Hung, et al.
Molecular Pharmaceutics
|
September 20, 2022
mRNA Treatment Rescues Niemann-Pick Disease Type C1 in Patient Fibroblasts
Denzil Furtado, Christina Cortez-Jugo, Ya Hui Hung, et al.
Journal of Neurochemistry
|
April 27, 1999
Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione
A R White, A I Bush, K Beyreuther, et al.
Page
of 52
Search research articles
Search
Showing results (111-120 of 517) with videos related to
Sort By:
Page
of 52
Drug News & Perspectives
|
December 13, 2006
Therapeutic treatments for Alzheimer's disease based on metal bioavailability
Peter J Crouch, Kevin J Barnham, Ashley I Bush, et al.
Molecular Psychiatry
|
October 26, 2016
Glutathione peroxidase 4: a new player in neurodegeneration?
B R Cardoso, D J Hare, A I Bush, et al.
The New England Journal of Medicine
|
August 28, 1980
The accuracy of the rectal examination in the diagnosis of prostate carcinoma
P Guinan, I Bush, V Ray, et al.
Parkinsonism & Related Disorders
|
November 1, 2018
Parkinson's disease prevalence and the association with rurality and agricultural determinants
Darshini Ayton, Scott Ayton, Anna L Barker, et al.
Metallomics : Integrated Biometal Science
|
May 22, 2015
Selenium, selenoproteins and neurodegenerative diseases
Bárbara Rita Cardoso, Blaine R Roberts, Ashley I Bush, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
June 6, 2009
beta-Amyloid as a molecular therapeutic target in Alzheimer's disease
Paul A Adlard, Simon A James, Ashley I Bush, et al.
International Journal of Alzheimer'S Disease
|
December 7, 2011
Disturbed copper bioavailability in Alzheimer's disease
Daniela Kaden, Ashley I Bush, Ruth Danzeisen, et al.
Biochimica Et Biophysica Acta. General Subjects
|
August 8, 2021
Copper and lipid metabolism: A reciprocal relationship
Bryce Blades, Scott Ayton, Ya Hui Hung, et al.
Molecular Pharmaceutics
|
September 20, 2022
mRNA Treatment Rescues Niemann-Pick Disease Type C1 in Patient Fibroblasts
Denzil Furtado, Christina Cortez-Jugo, Ya Hui Hung, et al.
Journal of Neurochemistry
|
April 27, 1999
Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione
A R White, A I Bush, K Beyreuther, et al.
Page
of 52